Literature DB >> 2841461

Coxsackie B viruses and myalgic encephalomyelitis.

E J Bell1, R A McCartney, M H Riding.   

Abstract

Data collected over the past 6 years suggest that Coxsackie B viruses (CBV) play an important role in myalgic encephalomyelitis (ME). Since psychological upset is a feature of this illness, 247 patients, recently admitted to a psychiatric hospital, were tested for neutralizing antibodies to CBV. A total of 12.5% had significantly raised CBV titres compared with 4-5% of 'well' control groups; the percentage positive was greatest (21%) in those aged 30-39 years. During 1985 and 1986 sera from 290 adults with ME were tested using the newly developed CBV IgM ELISA test; 37% were CBV IgM positive compared with 9% of 500 'well' adult controls. Forty-seven children, with ME were similarly tested during this period; 38% were positive, implying recent or active CBV infection. The combined use of this ELISA test and the virus probe techniques now available should further help to elucidate the exact role of CBV in this disabling illness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841461      PMCID: PMC1291624          DOI: 10.1177/014107688808100609

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  10 in total

1.  The postviral fatigue syndrome--an analysis of the findings in 50 cases.

Authors:  P O Behan; W M Behan; E J Bell
Journal:  J Infect       Date:  1985-05       Impact factor: 6.072

2.  Fatal Coxsackie B meningoencephalitis diagnosed by serology and in-situ nucleic acid hybridisation.

Authors:  N F Hallam; R P Eglin; P Holland; E J Bell; M V Squier
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

3.  Epidemic myalgic encephalomyelitis.

Authors:  P O Behan
Journal:  Practitioner       Date:  1980-08

4.  Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections.

Authors:  R A McCartney; J E Banatvala; E J Bell
Journal:  J Med Virol       Date:  1986-07       Impact factor: 2.327

5.  A study of Coxsackie B virus infections, 1972-1983.

Authors:  E J Bell; R A McCartney
Journal:  J Hyg (Lond)       Date:  1984-10

6.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

7.  Myalgic encephalomyelitis--report of an epidemic.

Authors:  K G Fegan; P O Behan; E J Bell
Journal:  J R Coll Gen Pract       Date:  1983-06

8.  Sporadic myalgic encephalomyelitis in a rural practice.

Authors:  B D Keighley; E J Bell
Journal:  J R Coll Gen Pract       Date:  1983-06

9.  Coxsackie B virus infection in coronary care unit patients.

Authors:  D O'Neill; J D McArthur; J A Kennedy; G Clements
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

10.  Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

Authors:  N E Bowles; P J Richardson; E G Olsen; L C Archard
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

  10 in total
  9 in total

1.  Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders.

Authors:  S Wessely; R Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

2.  Myalgic encephalomyelitis-a warning: discussion paper.

Authors:  S Wessely
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

3.  Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study.

Authors:  M Hotopf; N Noah; S Wessely
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Aerobic work capacity in patients with chronic fatigue syndrome.

Authors:  M S Riley; C J O'Brien; D R McCluskey; N P Bell; D P Nicholls
Journal:  BMJ       Date:  1990-10-27

5.  Management of chronic (post-viral) fatigue syndrome.

Authors:  S Wessely; A David; S Butler; T Chalder
Journal:  J R Coll Gen Pract       Date:  1989-01

Review 6.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

7.  Immune responsiveness in chronic fatigue syndrome.

Authors:  J D Milton; G B Clements; R H Edwards
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

8.  Sensory and cognitive event-related potentials in myalgic encephalomyelitis.

Authors:  D Prasher; A Smith; L Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-03       Impact factor: 10.154

Review 9.  The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

Authors:  Adam J O'Neal; Maureen R Hanson
Journal:  Front Med (Lausanne)       Date:  2021-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.